KISS
Go to Corporate Site
EN
TH
  • IR Home
  • Company Performance
    Company Performance

    The company intends to be Asia's future beauty and health leader by achieving

    • Key Investment Highlights
    • Quarterly Reports

    One Report 2024

    To Be Asia's Health & Beauty For Future

    Download
  • Stock Information
    Stock Information

    The Company’s goals, visions, and growing strategies. This will allow the Company to increase turnover and profits.

    • Stock Quote
    • Investment Calculator

    One Report 2024

    To Be Asia's Health & Beauty For Future

    Download
  • Publications
    Publications

    Accurate sharing of information accessible through a variety of channels.

    • Prospectus
    • Fact Sheets
    • Form 56-1 One Report
    • Presentations and Webcasts
    • Analyst Reports
    • Resource Center

    One Report 2024

    To Be Asia's Health & Beauty For Future

    Download
  • Shareholder Information
    Shareholder Information

    We continue to assure all stakeholders that we will continue to work creatively to develop market-ready beauty and wellness products.

    • Major Shareholders
    • Shareholder Meetings
    • Dividend Policy

    One Report 2024

    To Be Asia's Health & Beauty For Future

    Download
  • News and Events
    News and Events

    Developing the best beauty and health innovations that everyone can use.

    • SET Announcements
    • IR Press Releases
    • IR Events

    One Report 2024

    To Be Asia's Health & Beauty For Future

    Download
  • Information Inquiry
    Information Inquiry

    You can contact us for information of the company.

    • IR Contact
    • News Subscription

    One Report 2024

    To Be Asia's Health & Beauty For Future

    Download
  • Go to Corporate Site
  1. Home
  2. News and Events
  3. SET Announcements

SET Announcements

25 October 2022
The subscription of newly issued preferred shares in Hibiocy Co., Ltd., which is an asset acquisition by the Company, and the partial waiver of preferred share subscription in Hibiocy Co., Ltd., which is asset disposal by the Company
17 October 2022
Appointment of Chief Accountant
22 August 2022
Resignation of Chief Accountant
15 August 2022
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2022 (Revised)
15 August 2022
Interim Dividend Payment
15 August 2022
Management Discussion and Analysis Quarter 2 Ending 30 Jun 2022
15 August 2022
Financial Performance Quarter 2 (F45) (Reviewed)
15 August 2022
Financial Statement Quarter 2/2022 (Reviewed)
27 July 2022
Report of the utilization of capital increasing from Initial Public Offering (IPO) for the period ended 30 June 2022
13 May 2022
Financial Performance Quarter 1 (F45) (Reviewed)(Revised)
13 May 2022
Management Discussion and Analysis Quarter 1 Ending 31 Mar 2022
13 May 2022
Financial Statement Quarter 1/2022 (Reviewed)
  • 1
  • 2
  • ...
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
KISS
Investor Relations
Email: ir@rojukiss.com Tel: 02-645-1155 Call center: 02-645-1313
Copyright © 2025 Rojukiss International Public Company Limited. All right reserved
  • Terms and Conditions
  • Privacy Notice
  • Cookie Policy
  • Sitemap

Financial Statement Quarter 2/2022

Report of the Auditor
View Online Download
Financial Statement
View Online Download
Note to Financial Statement
View Online Download

Financial Statement Quarter 1/2022

Report of the Auditor
View Online Download
Financial Statement
View Online Download
Note to Financial Statement
View Online Download